Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
3.79
0.75 (24.67%)
At close: Aug 15, 2025, 3:59 PM
3.65
-3.57%
After-hours: Aug 15, 2025, 07:49 PM EDT

Immuneering Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-61.04M -53.47M -50.51M -33.54M
Depreciation & Amortization
n/a 352.08K 796.79K 159.07K
Stock-Based Compensation
6.5M 5.73M 4.06M 1.8M
Other Working Capital
-813.24K 119.84K -276.56K 751.1K
Other Non-Cash Items
461.05K -601.59K -166.21K 130.24K
Deferred Income Tax
n/a n/a n/a -307.49K
Change in Working Capital
-925.38K -974.64K 1.72M 900.42K
Operating Cash Flow
-55M -48.97M -44.1M -30.85M
Capital Expenditures
-84.88K -342.75K -742.48K -60.79K
Cash Acquisitions
n/a n/a -41.83M 70.35K
Purchase of Investments
n/a -44.66M -50.1M -75.63M
Sales Maturities Of Investments
n/a 52.3M 92.68M 75.62M
Other Investing Acitivies
26.43M n/a 41.83M -75.62M
Investing Cash Flow
26.43M 7.3M 41.83M -75.62M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.3M 241.07K 19K -842.76K
Financial Cash Flow
5.3M 28.44M 19K 144.26M
Net Cash Flow
-23.26M -13.23M -2.25M 37.8M
Free Cash Flow
-55.08M -49.31M -44.84M -30.91M